DTB Podcast

By BMJ Group

The Drug and Therapeutics Bulletin (DTB) Podcast is your source for practical, independent, and evidence-based information on drugs, medication, and prescribing.

Join the Editor-in-Chief and Deputy ... more

4.8

44 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about DTB Podcast:

How many episodes does DTB Podcast have?

The podcast currently has 183 episodes available.

DTB Podcast episodes:

September 05, 2025 Antibiotic susceptibility reports, deprescribing, and heart failure drugs
In this podcast accompanying the September issue of DTB (https://dtb.bmj.com/content/63/9), David Phizackerley (DTB Editor) is joined by Syba Sunny (DTB Clinical Editor). David and Syba discuss the editorial that highlights changes to antibiotic susceptibility reports, and in particular, the change to the 'I' classification from 'intermediate' to 'susceptible, increased exposure’ (https://dtb.bmj.com/content/63/9/130). They talk about a DTB Select article that summarises an evidence review of deprescribing interventions in primary care and the importance of collaborative multidisciplinary teams, education and training, and shared-decision making (https://dtb.bmj.com/content/63/9/131). They finish by discussing the main article that provides an overview of pharmacological management of chronic heart failure with reduced ejection fraction and the four main groups of drugs that form the four pillars of treatment (https://dtb.bmj.com/content/63/9/133).

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
18min
July 31, 2025 AI and DTB, drug safety, tirzepatide, and lecanemab for Alzheimer's disease
In this podcast accompanying the August issue of DTB (https://dtb.bmj.com/content/63/8), David Phizackerley (DTB Editor) is joined by James Cave (former DTB Editor-in-Chief). David and James discuss an editorial generated by artificial intelligence (AI) (https://dtb.bmj.com/content/63/8/114) which looks at the role of AI in publishing. They talk about a DTB Forum article (https://dtb.bmj.com/content/63/8/115) that explores some of the practical problems of implementing drug safety alerts. A DTB Select article (https://dtb.bmj.com/content/63/8/117) provides an overview of a double-blind, randomised, placebo-controlled trial of tirzepatide for weight reduction in people without diabetes. They finish by reviewing the main article (https://dtb.bmj.com/content/63/8/118) that provides an overview of the evidence for lecanemab for the treatment of mild cognitive impairment and mild dementia due to Alzheimer’s disease.

Link
BMJ policy on AI use: https://www.bmj.com/content/ai-use

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
39min
July 01, 2025 National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis
In this podcast accompanying the July issue of DTB (https://dtb.bmj.com/content/63/7), David Phizackerley (DTB Editor) is joined by Syba Sunny (Clinical Editor). David and Syba discuss the editorial (https://dtb.bmj.com/content/63/7/98) which focuses on some key changes in the new national asthma guideline and the implications for patients and healthcare professionals. A DTB Select article (https://dtb.bmj.com/content/63/7/99) provides an overview of a double-blind randomised placebo-controlled trial that assessed whether bisoprolol reduced the number of exacerbations in people with COPD. The main article (https://dtb.bmj.com/content/63/7/103) is an overview of abaloparatide, which is licensed for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.

The podcast begins with a discussion about ideas for new articles for DTB and the therapeutic areas currently under consideration. If you have a suggestion for an article that you would like DTB to cover, please email details to [email protected].

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
23min
June 03, 2025 Identifying VTE in early pregnancy, gabapentinoids and COPD, managing ADHD
In this podcast accompanying the June issue of DTB, David Phizackerley (DTB Editor) is joined by Julian Treadwell (DTB Associate Editor) and Laurence Leaver (GP). David and Julian start by discussing the editorial - https://dtb.bmj.com/content/63/6/82 - which highlights some of the challenges in preventing VTE in early pregnancy. They also talk about a cohort study - https://dtb.bmj.com/content/63/6/84 - that assessed whether gabapentinoid use was associated with severe exacerbations among patients aged >55 years with chronic obstructive pulmonary disease (COPD). In the second half of the podcast, Julian talks to Laurence about two articles - https://dtb.bmj.com/content/63/5/74 and https://dtb.bmj.com/content/63/6/85 - he wrote on managing ADHD in adults.

Their discussion includes issues relating to diagnosis, effectiveness of medication, starting and titrating medication and some of the common adverse effects associated with medication. Both articles are currently free to access on the DTB website.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
40min
May 09, 2025 The polypill revisited, cytisinicline for vaping cessation and a new co-host
In this podcast accompanying the May issue (https://dtb.bmj.com/content/63/5) of DTB, David Phizackerley (DTB Editor) welcomes Syba Sunny (DTB Clinical Editor) to the podcast. Syba provides an overview of her role with DTB, discusses her previous work as a Consultant Microbiologist and talks about areas of interest for future DTB articles. The editorial (https://dtb.bmj.com/content/63/5/66) discusses a paper in The BMJ which proposed offering a polypill containing rosuvastatin, hydrochlorothiazide, amlodipine and losartan to all people in the UK over the age of 50 years to reduce the risk of heart attacks and strokes.
A DTB Select item (https://dtb.bmj.com/content/63/5/68) summarises the results of a small study that assessed whether cytisinicline (cytisine) plus behavioural support was more effective than behavioural support alone for vaping cessation. The main article (https://dtb.bmj.com/content/63/5/74) is the first of two articles on the medical management of ADHD and there will be a longer discussion and an interview with the author in the June podcast.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
20min
April 02, 2025 Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD
In this podcast recorded in early March, David Phizackerley (DTB Editor-in-Chief) and James Cave (DTB Editor-in-Chief Emeritus) provide an overview of the April 2025 issue of DTB. The editorial discusses concerns over the use of feminist empowerment messages to sell tests and treatments - https://dtb.bmj.com/content/63/4/50. A DTB Select item summarises the results of an observational study that assessed the association between initiation of a triptan and the risk of myocardial infarction or stroke - https://dtb.bmj.com/content/63/4/51. The main article provides an overview of initiating angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists in adults with CKD, highlighting current guideline recommendations and providing a practical approach to dealing with the challenges associated with their use - https://dtb.bmj.com/content/63/4/54.

Links
Health Innovation Network: https://thehealthinnovationnetwork.co.uk/news/launch-of-new-game-changing-guide-to-tackle-overprescribing-and-support-governments-shifts-to-prevention-and-community/

Tackling overprescribing report: https://thehealthinnovationnetwork.co.uk//wp-content/uploads/2025/02/Health-Innovation-Network-Polypharmacy-Guide-Feb-2025.pdf

GP Evidence: (https://gpevidence.org/)

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
29min
March 03, 2025 Paying the price, liver problems with fezolinetant, systemic anticancer treatments
In this podcast recorded in early February, David Phizackerley and Julian Treadwell (DTB Associate Editor) provide an overview of the March 2025 issue of DTB. Julian talks about his work as an academic GP based at Bristol University. He explains why and how he developed the GP Evidence website (https://gpevidence.org/) as a resource for health professionals to use as part of a shared decision making process, and talks about the importance of providing patients with information on the absolute benefits and harms of different treatment options for long-term conditions.

The editorial discusses a paper published in The Lancet on the population-health impact of new drugs recommended by NICE and highlights the tension between NICE's role in ensuring that treatments are a cost-effective use of taxpayers’ money and its role in championing the for-profit life-sciences - https://dtb.bmj.com/content/63/3/34. A DTB Select item summarises safety alerts issued by the US Food and Drug Administration and the European Medicines Agency on liver problems associated with fezolinetant (▼Veoza), a drug licensed for the treatment of moderate-to-severe
vasomotor symptoms associated with the menopause - https://dtb.bmj.com/content/63/3/36. The main article provides an overview of systemic anticancer treatments and conventional cytotoxic drugs - https://dtb.bmj.com/content/63/3/37.

Links
GP Evidence (https://gpevidence.org/)

Naci H, Murphy P, Woods B, et al. Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis. The Lancet 2025;405:50–60. (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02352-3/fulltext)

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
32min
January 27, 2025 Prioritising shared decision making, remission from type 2 diabetes, gefapixant for cough
In this podcast recorded in early January, David Phizackerley provides a brief overview of the February 2025 issue of DTB. The editorial discusses the importance of shared decision making and calls on guideline developers to produce patient decision aids to accompany their guidance - https://dtb.bmj.com/content/63/2/18. A DTB Select item summarises a study that evaluated implementation of NHS England’s type 2
diabetes path to remission programme - https://dtb.bmj.com/content/63/2/19. The authors of a DTB Commentary article review a UK primary care study which reported that treatment with antihypertensive medicines in older people with complex health needs was associated with an increased risk of
acute kidney injury (AKI) and a short-term increased risk of falls - https://dtb.bmj.com/content/63/2/20. The main article explores the evidence for gefapixant in the treatment of refractory or unexplained chronic cough in adults - https://dtb.bmj.com/content/63/2/22.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email [email protected]. Thank you for listening.
...more
10min
December 30, 2024 PILs: all harms and no benefits, Irish College of GPs end pharma funding, Ryeqo for fibroids
In this podcast recorded in early December, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the January 2025 issue of DTB. They provide an overview of the editorial that questions whether it is time for the medicine Patient Information Leaflet (PIL) to include information on the impact of a medicine on clinical outcomes - https://dtb.bmj.com/content/63/1/2. They talk about a recent announcement from the Irish College of GPs that it is phasing out sponsorship from pharmaceutical companies as evidence suggests that ‘engagement between pharmaceutical companies and prescribers is associated with inappropriately increased prescribing rates, lower prescribing quality and increased prescription costs’ - https://dtb.bmj.com/content/63/1/3. The main article provides an overview of Ryeqo (relugolix, estradiol and norethisterone acetate) for the treatment of moderate to severe symptoms of uterine fibroids - https://dtb.bmj.com/content/63/1/6. The podcast ends with a farewell to James, who is stepping down as Editor-in-Chief after more than 12 years. James reflects on his time as a doctor, GP and Editor of DTB.

Other links:
Is ASCOT all it's cracked up to be? https://www.bmj.com/content/331/7523/1023.1
Don't lose your head over ASCOT https://www.bmj.com/content/331/7523/1022.1
...more
29min
November 28, 2024 When it comes to drugs, sex matters; menopausal HT and dementia; daridorexant for sleep
In this podcast recorded in early November, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December issue of DTB. They provide an overview of the editorial that discusses the need to record the sex and gender of all participants in clinical trials and the importance of recognising diversity and inclusivity in clinical research - https://dtb.bmj.com/content/62/12/178. They talk about a commentary article that addresses claims made in a systematic review that menopausal HT may support neurological function and reduce the risk of Alzeheimer's disease - https://dtb.bmj.com/content/62/12/179. The main article provides an overview of daridorexant for the management of chronic sleep - https://dtb.bmj.com/content/62/12/183.
They begin by providing an update on the NICE guidance for tirzepatide and highlighting the publication of a toolkit for repeat prescribing in general practice.

Other related links
NICE guidance on tirzepatide: https://www.nice.org.uk/guidance/gid-ta11156/documents/html-content-10
Repeat prescribing toolkit: https://www.rpharms.com/resources/repeat-prescribing-toolkit
...more
28min

FAQs about DTB Podcast:

How many episodes does DTB Podcast have?

The podcast currently has 183 episodes available.

More shows like DTB Podcast

Woman's Hour by BBC Radio 4

Woman's Hour

400 Listeners

Health Check by BBC World Service

Health Check

93 Listeners

Inside Health by BBC Radio 4

Inside Health

110 Listeners

Medicine and Science from The BMJ by The BMJ

Medicine and Science from The BMJ

41 Listeners

BJSM Podcast by BMJ Group

BJSM Podcast

49 Listeners

Gut Podcast by BMJ Group

Gut Podcast

7 Listeners

Sharp Scratch by The BMJ

Sharp Scratch

5 Listeners

ADC Podcast by BMJ Group

ADC Podcast

3 Listeners

Thorax Podcast by BMJ Group

Thorax Podcast

1 Listeners

STI Podcast by BMJ Group

STI Podcast

3 Listeners

JNNP Podcast by BMJ Group

JNNP Podcast

9 Listeners

Heart Podcast by BMJ Group

Heart Podcast

38 Listeners

JNIS Podcast by BMJ Group

JNIS Podcast

14 Listeners

EBN Podcast by BMJ Group

EBN Podcast

1 Listeners

Practical Neurology Podcast by BMJ Group

Practical Neurology Podcast

49 Listeners

FG Podcast by BMJ Group

FG Podcast

0 Listeners

Medical Humanities Podcast by BMJ Group

Medical Humanities Podcast

6 Listeners

Lupus Science and Medicine Podcast by BMJ Group

Lupus Science and Medicine Podcast

15 Listeners

ARD Podcast by BMJ Group

ARD Podcast

3 Listeners

The Good GP by The Good GP

The Good GP

14 Listeners

RMD Open Podcast by BMJ Group

RMD Open Podcast

3 Listeners

BMJ Best Practice Podcast by BMJ Group

BMJ Best Practice Podcast

24 Listeners

IJGC Podcast by BMJ Group

IJGC Podcast

23 Listeners

Primary Care Knowledge Boost by Primary Care Knowledge Boost

Primary Care Knowledge Boost

46 Listeners

You Are Not A Frog by Dr Rachel Morris

You Are Not A Frog

8 Listeners

RCGP eLearning Podcast by RCGP eLearning Podcast

RCGP eLearning Podcast

6 Listeners

GPnotebook Podcast by GPnotebook

GPnotebook Podcast

22 Listeners

NB Hot Topics Podcast by NB Medical Education

NB Hot Topics Podcast

5 Listeners

The Curious Clinicians by The Curious Clinicians

The Curious Clinicians

368 Listeners

Medics Money podcast by Medics Money

Medics Money podcast

6 Listeners

Red Whale Primary Care Pod by Red Whale

Red Whale Primary Care Pod

6 Listeners

Talking Meds - A PrescQIPP podcast by PrescQIPP C.I.C.

Talking Meds - A PrescQIPP podcast

0 Listeners